results hemoglobin level was 9.9 ± 5.1 in the control group six hours after hemorrhage while it was 8.10 ± 2.1 in the treatment group (p = 0.004). hemoglobin level was 5.8 ± 4.1 in the control who did not receive transfusion of blood products during the first 24 hours after hemorrhage, while this level was 7.9 ± 4.1 in the treatment group (p = 0.001). the amount of bleeding significantly declin...

background thalassemia patients are at risk of blood borne viral infections because of repeated transfusion of blood products. objectives we aimed to determine the prevalence of hepatitis c virus (hcv) infection in these patients in zabol, iran. methods this study was conducted on 152 patients with thalassemia at the center of special diseases of zabol. demographic data were collected and serum...

background and objective: patients with thalassemia major have an abnormality in hemoglobin synthesis and ineffective hematopoiesis and for this reason with respect to disease severity should receive one or more fresh blood unit every 15-30 days. since transfusion of blood products has been known as one of the routes of hiv infection, therefore, this study was conducted to evaluate the prevalen...

Blood is a liquid tissue in which dissolved with abundant chemical factors and millions of different cells The reduction of unwanted side effects, especially diseases that emerge through blood such as HIV and hepatitis, has a significant role for modern medicine of transfusion and transplantation. The issues and costs of human blood collection and storage, direct this procedure towards t...

background beta-thalassemia patients receive blood products from blood transfusion centers repeatedly. blood transfusion can transmit cytomegalovirus (cmv) and toxoplasma gondii. the aim of this study was serological evaluation of these two infectious agents in thalassemia patients. materials and methods in a cross-sectional study, the enzymelinked immunosorbent assay (elisa) testing was perfor...

This paper presents a multi-periodic, multi-echelon blood supply chain network consisting of blood donors, mobile collection units, local blood centers, main blood centers and demand points in which the local and main blood centers are subject to random failure in dispatching blood products to demand points. The problem has two objectives including minimization of the total chain costs and maxi...